Markowski, A.; Zaremba-Czogalla, M.; Jaromin, A.; Olczak, E.; Zygmunt, A.; Etezadi, H.; Boyd, B.J.; Gubernator, J.
Novel Liposomal Formulation of Baicalein for the Treatment of Pancreatic Ductal Adenocarcinoma: Design, Characterization, and Evaluation. Pharmaceutics 2023, 15, 179.
https://doi.org/10.3390/pharmaceutics15010179
AMA Style
Markowski A, Zaremba-Czogalla M, Jaromin A, Olczak E, Zygmunt A, Etezadi H, Boyd BJ, Gubernator J.
Novel Liposomal Formulation of Baicalein for the Treatment of Pancreatic Ductal Adenocarcinoma: Design, Characterization, and Evaluation. Pharmaceutics. 2023; 15(1):179.
https://doi.org/10.3390/pharmaceutics15010179
Chicago/Turabian Style
Markowski, Adam, Magdalena Zaremba-Czogalla, Anna Jaromin, Ewa Olczak, Adrianna Zygmunt, Haniyeh Etezadi, Ben J. Boyd, and Jerzy Gubernator.
2023. "Novel Liposomal Formulation of Baicalein for the Treatment of Pancreatic Ductal Adenocarcinoma: Design, Characterization, and Evaluation" Pharmaceutics 15, no. 1: 179.
https://doi.org/10.3390/pharmaceutics15010179
APA Style
Markowski, A., Zaremba-Czogalla, M., Jaromin, A., Olczak, E., Zygmunt, A., Etezadi, H., Boyd, B. J., & Gubernator, J.
(2023). Novel Liposomal Formulation of Baicalein for the Treatment of Pancreatic Ductal Adenocarcinoma: Design, Characterization, and Evaluation. Pharmaceutics, 15(1), 179.
https://doi.org/10.3390/pharmaceutics15010179